Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
01 March 2022 | Story Lunga Luthuli | Photo Charl Devenish
UFS staff members
All smiles – pictured are inspired University of the Free State staff ready to live, serve with excellence, and care for the growth of the institution.

The Division of Organisational Development and Employee Well-being within the Department of Human Resources’ iRecognise initiative is another University of the Free State (UFS) initiative to appreciate and recognise staff dedication and excellence. 

Through the peer-to-peer iRecognise platform, UFS staff members have the opportunity to recognise colleagues from different units, divisions, faculties, and campuses. 

Natasha Nel, UFS Organisational Development specialist, said: “iRecognize is an open acknowledgment and expressed appreciation for employees’ contributions. A strong recognition culture can help individuals and organisations perform better. Employees, teams, and the university all benefit from frequent and meaningful feedback and appreciation.”

“It is a promotion of positive behaviour that supports individuals, teams, divisions, and departments in achieving the university’s vision and goals. The UFS wants to create a culture of mutual respect, reward, and recognition for employees at all levels in a non-monetary award based on significance,” she said.

The criteria for staff to recognise colleagues include timeliness, authenticity, and specificity, and the badges that staff members can use is also aligned with the university’s competency framework. The platform also includes an option to send recognition privately. 

“Employees who feel recognised and appreciated are more engaged, productive, and innovative, despite what may appear to be common sense. Employee appreciation is a potent motivator and reinforcer of positive behaviour,” Nel said.

Nel said: “Recognition reinforces acts and behaviour that improve everyone's working environment. Although recognition is free, it improves employee productivity, engagement, and quality of work.”

The recognition platform has other capabilities that the Division of Organisational Development and Employee Well-being would like to incorporate in the future, and staff can continue to nominate their colleagues for their excellence. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept